Mediwelcome Reshuffles Company Secretary and Authorized Representatives

Mediwelcome Healthcare Management & Technology Inc. ( (HK:2159) ) just unveiled an update.

Mediwelcome Healthcare Management & Technology Inc. has announced a series of senior corporate governance changes effective 23 February 2026, including the resignation of company secretary and authorized representative Ms. Tsoi Siu Wai, who is also stepping down as the firm’s Hong Kong process agent. She leaves without disagreement with the board, and the company has expressed its appreciation for her contributions during her tenure.

The board has appointed Ms. Chen Ming Mei Josephine as the new company secretary, authorized representative and process agent, bringing more than 20 years of corporate services and compliance experience with Hong Kong listed and offshore companies. In a parallel move, chairman and executive director Shi Wei has resigned as an authorized representative under the listing rules, with executive director and chief financial officer Deng Chengying assuming that role, signaling a redistribution of governance and compliance responsibilities within the senior management team.

The most recent analyst rating on (HK:2159) stock is a Sell with a HK$1.00 price target. To see the full list of analyst forecasts on Mediwelcome Healthcare Management & Technology Inc. stock, see the HK:2159 Stock Forecast page.

More about Mediwelcome Healthcare Management & Technology Inc.

Mediwelcome Healthcare Management & Technology Inc., incorporated in the Cayman Islands and listed in Hong Kong, operates in the healthcare management and technology sector. The company is governed by a board comprising executive, non-executive and independent non-executive directors, reflecting a typical Hong Kong-listed corporate structure.

Average Trading Volume: 324,604

Technical Sentiment Signal: Strong Buy

Current Market Cap: HK$364M

Learn more about 2159 stock on TipRanks’ Stock Analysis page.